Invus - Unicorn Nest



This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, New York


Invus was established in 1985, and is a well known VC. The primary office of this VC is located in New York. The fund is located in United States, North America.

Besides the listed founders, we have found 18 key employees of this fund in our database.

The most exits for the fund occurred in 2019. The most common rounds for this fund are in the range of 50 - 100 millions dollars. The fund performance shows that this VC achieves 14 percentage points more exits in comparison to other VCs. At the time of investment by Invus, a typical start-up valuation would be 500 millions - 1 billion dollars. The fund typically enters into 2-6 deals annually. In 2019, the fund's activity was at its peak. In addition, the fund was active in 2019. Invus participates, on average, in 14 percentage points less than the average amount of lead investments in other funds.

Moderna Therapeutics, Kythera Biopharmaceuticals, Gossamer Bio are amongst the various portfolio companies of this fund. The fund has no specific requirements for the number of founders in a start-up. When a start-up has 5+ founders, the probability of closing the deal is low. Among the most popular investment industries for the fund are Biotechnology, Software. However, the fund’s focus is not limited to this, since there are 25 more areas of investment. The country of its foundation and the country of its most frequent investments coincides - United States. Besides this, the fund also invested in 10 other countries. Moreover, a start-up needs to be 6-10 years old to get investment from this fund.

The usual method for the fund is to invest in rounds with 5-6 other investors. Aside from Invus, start-ups are often funded by Polaris Partners, Versant Ventures, The Column Group and 55 other funds. Other VCs who often invest in the same rounds are Fidelity Management and Research Company, Polaris Partners, Redmile Group, the total number of co-investors is 62. The investors in the following rounds are usually InterWest Partners, Wipro Technologies, Wing Venture Capital, and 13 VCs in total.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first_initial last, first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

84.6% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

21.1% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

4.8 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.53 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]


Funds Investing in Previous

Polaris Partners, Versant Ventures, The Column Group

Funds Investing in Following

InterWest Partners, Wipro Technologies, Wing Venture Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: